Shelter Pharma Limited Secures$18,300 Export Order From First Vet Veterinary Medicines Trading LLC; Shares Dip 0.17%

Mumbai, March 12: Shelter Pharma Limited informed the exchange on Thursday that it has secured an international supply order from First Vet Veterinary Medicines Trading LLC, UAE for veterinary and animal healthcare products valued at $18,300, according to a regulatory disclosure filed under Regulation 30(4) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The contract involves the supply of veterinary and animal healthcare products to the UAE based entity. As outlined in the disclosure annexure, the order is structured on a fixed cost basis and is scheduled to be executed within six months. The company confirmed that the awarding entity is an international customer and that the transaction does not fall under related party transactions. The filing also clarified that neither the promoter nor promoter group entities have any interest in the awarding company.

Stock Market Snapshot

Shelter Pharma share price traded lower during the afternoon session on March 12, 2026. The stock was priced at ₹34.49, down 0.17% from the previous close of ₹34.55, as of 1:12 PM IST, according to exchange-tracked market data.

During the session the stock opened at ₹34.60 and touched a low of ₹33.50 and a high of ₹34 range so far. The company’s market capitalisation stood near ₹57.29 crore with a price to earnings ratio of 6.37 based on available market statistics.

Company Background

Shelter Pharma Limited operates in the pharmaceutical and nutraceutical segments with a focus on healthcare formulations and wellness products. The company develops and markets nutraceuticals and related healthcare solutions aimed at improving quality of life through research driven product development.

According to company disclosures, its operational focus includes innovation in nutraceutical formulations, quality controlled manufacturing processes and expanding distribution channels across domestic and international markets.

The company also maintains export linkages in selected overseas markets where demand exists for nutraceutical and animal healthcare formulations.

Conclusion

The UAE order represents a small international export contract for Shelter Pharma, reinforcing its presence in overseas veterinary healthcare supply chains. Execution of the contract within the six-month timeline will contribute incremental export revenue, though the disclosed order size remains relatively modest in financial scale.

Source:

• https://www.bseindia.com/xml-data/corpfiling/AttachLive/f5422b3f-cd46-472e-aef9-20cca70f5c2c.pdf
• https://www.bseindia.com/stock-share-price/shelter-pharma-ltd/shelter/543963/